Skip to main content
OpenTrials

Clinical trial condition

Hyperpituitarism

Explore clinical trials studying Hyperpituitarism. Study availability and eligibility vary by location and protocol.

211 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Hyperpituitarism trial results

Completed

Open-label Treatment in Cushing's Syndrome

NCT03621280

Conditions
Adrenal Gland Diseases, Adrenocortical Hyperfunction, Brain Diseases, +9 more
Locations
  • The Center for Diabetes and Endocrine Care Fort Lauderdale, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • University of New Mexico HSC - HSC Sponsored Projects Office Albuquerque, New Mexico, United States
View all 30 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)

NCT03792555

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Ohio State University Columbus, Ohio, United States
  • The Research Institute of Dallas Dallas, Texas, United States
  • CETI - Centro de Estudos em Terapias Inovadoras Curitiba, Brazil
  • CPQuali Pesquisa Clinica São Paulo, Brazil
View Trial Details
Completed

An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge)

NCT03789656

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • UCLA Gonda Diabetes Center Los Angeles, California, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
View all 26 locations
View Trial Details
Completed

Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China

NCT05431803

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Peking Union Medical College Hospital (PUMCH) Beijing, China
  • Peking University Third Hospital (PUH3) Beijing, China
  • Xiangya Hospital Central South University (XYHCSU) Changsha, China
  • West China Hospital，Sichuan University (WCH) Chengdu, China
View Trial Details
Completed

Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease

NCT02310269

Conditions
Adrenal Gland Diseases, Adrenocortical Hyperfunction, Brain Diseases, +8 more
Locations
  • St Josephs Hospital and Medical Center Phoenix, Arizona, United States
  • University of Southern California CSOM230B2410 - SC Los Angeles, California, United States
  • Massachusetts General Hospital SC - SOM230B2410 Boston, Massachusetts, United States
  • Ohio State University SC - SOM230B2410 Columbus, Ohio, United States
View all 54 locations
View Trial Details
Completed

A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly

NCT04522180

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Palm Research Center Inc. Las Vegas, Nevada, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 22 locations
View Trial Details

Related conditions